FDA Grants Third Approval Under the National Priority Voucher Program
For Immediate Release: March 05, 2026 The U.S. Food and Drug Administration today approved teclistamab in combination with daratumumab hyaluronidase-fihj, Tec-Dara, to treat adult patients with relapsed or refractory multiple myeloma who have received at …